JAAD online
A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria

https://doi.org/10.1016/j.jaad.2010.03.007Get rights and content

First page preview

First page preview
Click to open first page preview

References (5)

  • N. Scheinfeld

    The new antihistamines—desloratadine and levocetirizine: a review

    J Drugs Dermatol

    (2002)
  • J.H. Day et al.

    Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU)

    Int J Clin Pract

    (2004)
There are more references available in the full text version of this article.

Cited by (10)

  • Treatment of chronic spontaneous urticaria: Immunomodulatory approaches

    2018, Clinical Immunology
    Citation Excerpt :

    Several randomized (placebo) controlled trials have proved their efficiency in CSU [31]. Cetirizine seems to be more effective than fexofenadine [32] and levocetirizine more effective than desloratadine [33]. However, rupatadine seems to be more effective than cetirizine [34], while levocetirizine seems to be more effective than rupatadine in another study [35].

  • Treatment of chronic urticaria: What's new?

    2011, Revue Francaise d'Allergologie
  • H1-antihistamines for chronic spontaneous urticaria

    2014, Cochrane Database of Systematic Reviews
View all citing articles on Scopus

Supported by Lotus Pharmaceutical, Taipei, Taiwan.

Conflicts of interest: None declared.

View full text